Article Versions Notes

Faldoni FLC, Villacis RAR, Canto LM, Fonseca-Alves CE, Cury SS, Larsen SJ, Aagaard MM, Souza CP, Scapulatempo-Neto C, Osório CABT, et al. Inflammatory Breast Cancer: Clinical Implications of Genomic Alterations and Mutational Profiling. Cancers. 2020; 12(10):2816. https://doi.org/10.3390/cancers12102816

Faldoni, Flávia L. C., Rolando A. R. Villacis, Luisa M. Canto, Carlos E. Fonseca-Alves, Sarah S. Cury, Simon J. Larsen, Mads M. Aagaard, Cristiano P. Souza, Cristovam Scapulatempo-Neto, Cynthia A. B. T. Osório, and et al. 2020. "Inflammatory Breast Cancer: Clinical Implications of Genomic Alterations and Mutational Profiling" Cancers 12, no. 10: 2816. https://doi.org/10.3390/cancers12102816

Faldoni, F. L. C., Villacis, R. A. R., Canto, L. M., Fonseca-Alves, C. E., Cury, S. S., Larsen, S. J., Aagaard, M. M., Souza, C. P., Scapulatempo-Neto, C., Osório, C. A. B. T., Baumbach, J., Marchi, F. A., & Rogatto, S. R. (2020). Inflammatory Breast Cancer: Clinical Implications of Genomic Alterations and Mutational Profiling. Cancers, 12(10), 2816. https://doi.org/10.3390/cancers12102816